X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs VENUS REMEDIES - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD VENUS REMEDIES STRIDES SHASUN LTD/
VENUS REMEDIES
 
P/E (TTM) x 34.7 -571.1 - View Chart
P/BV x 0.9 0.2 572.4% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 STRIDES SHASUN LTD   VENUS REMEDIES
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
VENUS REMEDIES
Mar-17
STRIDES SHASUN LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,275143 892.6%   
Low Rs91865 1,412.3%   
Sales per share (Unadj.) Rs389.6324.2 120.2%  
Earnings per share (Unadj.) Rs28.06.4 436.3%  
Cash flow per share (Unadj.) Rs48.940.6 120.5%  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs303.1366.0 82.8%  
Shares outstanding (eoy) m89.4212.34 724.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.80.3 878.1%   
Avg P/E ratio x39.216.2 241.8%  
P/CF ratio (eoy) x22.42.6 875.6%  
Price / Book Value ratio x3.60.3 1,274.0%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m98,0361,282 7,646.3%   
No. of employees `0005.80.9 642.3%   
Total wages/salary Rs m5,881251 2,343.1%   
Avg. sales/employee Rs Th6,005.94,430.1 135.6%   
Avg. wages/employee Rs Th1,014.0278.0 364.8%   
Avg. net profit/employee Rs Th431.287.6 492.2%   
INCOME DATA
Net Sales Rs m34,8344,000 870.8%  
Other income Rs m1,68623 7,426.4%   
Total revenues Rs m36,5204,023 907.8%   
Gross profit Rs m6,428785 819.2%  
Depreciation Rs m1,872422 443.9%   
Interest Rs m2,269344 660.3%   
Profit before tax Rs m3,97342 9,437.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470-37 -1,270.3%   
Profit after tax Rs m2,50179 3,161.7%  
Gross profit margin %18.519.6 94.1%  
Effective tax rate %11.8-87.9 -13.5%   
Net profit margin %7.22.0 363.1%  
BALANCE SHEET DATA
Current assets Rs m38,1652,606 1,464.4%   
Current liabilities Rs m30,4021,980 1,535.2%   
Net working cap to sales %22.315.6 142.4%  
Current ratio x1.31.3 95.4%  
Inventory Days Days77128 60.3%  
Debtors Days Days10443 242.1%  
Net fixed assets Rs m37,6395,353 703.1%   
Share capital Rs m894123 724.6%   
"Free" reserves Rs m26,2104,393 596.7%   
Net worth Rs m27,1054,516 600.2%   
Long term debt Rs m16,3771,618 1,012.1%   
Total assets Rs m81,1688,291 979.0%  
Interest coverage x2.81.1 245.1%   
Debt to equity ratio x0.60.4 168.6%  
Sales to assets ratio x0.40.5 88.9%   
Return on assets %5.95.1 115.2%  
Return on equity %9.21.8 526.8%  
Return on capital %12.16.3 191.6%  
Exports to sales %00-   
Imports to sales %018.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA736 0.0%   
Fx inflow Rs m13,4650-   
Fx outflow Rs m4,076736 553.5%   
Net fx Rs m9,389-736 -1,275.2%   
CASH FLOW
From Operations Rs m2,881997 288.9%  
From Investments Rs m-7,051-461 1,528.5%  
From Financial Activity Rs m3,382-571 -592.3%  
Net Cashflow Rs m-788-35 2,243.8%  

Share Holding

Indian Promoters % 27.7 32.9 84.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 0.2 21,000.0%  
FIIs % 8.6 0.6 1,482.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 66.4 39.0%  
Shareholders   56,241 20,121 279.5%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 145 Points Up; Sun Pharma Rallies on Strong Earnings(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is flat while the Hang Seng is up 0.7%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


May 28, 2018 10:45 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS